BioNTech to shut three German manufacturing sites after sale talks fall through

BioNTech announced it will close three of its manufacturing facilities in Germany. The decision follows months of searching for buyers for the sites.

The company said it was unable to secure a deal despite intensive efforts by all parties involved. As a result, the facilities will be shut down.

The closures highlight challenges in finding buyers for large‑scale pharma manufacturing assets in Europe and may affect BioNTech's production capacity in the region.